Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Up 115.6% in October

Enzolytics, Inc. (OTCMKTS:ENZC) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 1,260,500 shares, a growth of 115.6% from the September 30th total of 584,700 shares. Based on an average trading volume of 17,960,300 shares, the days-to-cover ratio is currently 0.1 days.

Enzolytics Stock Performance

OTCMKTS ENZC remained flat at $0.00 during trading on Friday. The company’s stock had a trading volume of 9,293,308 shares, compared to its average volume of 10,409,088. Enzolytics has a 12 month low of $0.00 and a 12 month high of $0.03.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.